Calidi Biotherapeutics Receives Pre-IND Regulatory Feedback From FDA Providing Alignment, Clarity On IND-Enabling Preclinical Plans And Clinical Strategy For CLD-401 Prior To Advancing Drug Candidate Into Phase 1 Clinical Studies
Calidi Biotherapeutics Inc CLDI
$0.17
▲ +11.12%
(+$0.02)
Open
$0.15
Prev Close
$0.15
Day Range
$0.15 – $0.17
52W Range
$0.12 – $19.20
Market Cap
$3.26M
Beta
1.36
EPS (TTM)
$-4.00
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2021-09-10 |
| Shares Out. | 19,310,000 |
| Website | calidibio.com/ ↗ |
| Phone | 18587949600 |
Calidi Biotherapeutics Inc is a publicly traded company under the ticker symbol CLDI on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-06-01)